APA (7th ed.) Citation

Kytö, V., Saraste, A., Rautava, P., & Tornio, A. (2022). Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillation. Basic & Clinical Pharmacology & Toxicology, 130(6), 655. https://doi.org/10.1111/bcpt.13733

Chicago Style (17th ed.) Citation

Kytö, Ville, Antti Saraste, Päivi Rautava, and Aleksi Tornio. "Digoxin Use and Outcomes After Myocardial Infarction in Patients with Atrial Fibrillation." Basic & Clinical Pharmacology & Toxicology 130, no. 6 (2022): 655. https://doi.org/10.1111/bcpt.13733.

MLA (9th ed.) Citation

Kytö, Ville, et al. "Digoxin Use and Outcomes After Myocardial Infarction in Patients with Atrial Fibrillation." Basic & Clinical Pharmacology & Toxicology, vol. 130, no. 6, 2022, p. 655, https://doi.org/10.1111/bcpt.13733.